Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey

Disability and Rehabilitation
Matthew J Carlson, Gloria Krahn

Abstract

To estimate the prevalence of complementary and alternative medicine (CAM) practitioner use, assess the reasons for use, and determine the symptoms for which CAM practitioners were consulted in a national US sample of insured adults with physical disabilities. Data for this study come from a longitudinal survey conducted in 2000 and 2001 on a national sample of 830 adults with health insurance who had one of four disabling conditions: multiple sclerosis, cerebral palsy, spinal cord injury, and arthritis. Estimates of annual prevalence and reasons and symptoms for which CAM practitioners were consulted are derived from cross-sectional analysis of the 2001 survey data. Prior use of CAM was assessed using the 2000 survey. CAM practitioners were consulted by 19% of the sample, a rate similar to, or higher than the general population. CAM use was more prevalent among women than men (24 vs. 10%), in the Western US (30%) compared to the Midwest (20%) Northeast (14%), and South (10%) and among prior users (62%) compared to non-users (8%). There were no significant differences in CAM use by condition, although individuals with spinal cord injury reported the lowest use (14%). Common symptoms treated were pain (80%), decreased functionin...Continue Reading

References

Jan 28, 1993·The New England Journal of Medicine·D M EisenbergT L Delbanco
Feb 1, 1996·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·M Pioro-BoissetM A Fitzcharles
Mar 1, 1997·Archives of Family Medicine·N C ElderR Minz
May 20, 1998·American Journal of Public Health·E L HurwitzP G Shekelle
May 30, 1998·JAMA : the Journal of the American Medical Association·J A Astin
Aug 26, 1998·Archives of Physical Medicine and Rehabilitation·S F WainapelB S Kahan
Nov 20, 1998·JAMA : the Journal of the American Medical Association·D M EisenbergR C Kessler
Nov 20, 1998·Archives of Physical Medicine and Rehabilitation·H H KraussD M Eisenberg
Sep 25, 1999·Annals of Internal Medicine·J K RaoM Weinberger
Oct 12, 1999·JAMA : the Journal of the American Medical Association·B G Druss, R A Rosenheck
Nov 4, 2000·BMJ : British Medical Journal·E Ernst
Aug 21, 2001·Annals of Internal Medicine·R C KesslerD M Eisenberg
Jul 10, 2002·The Milbank Quarterly·Gerben DejongMelinda T Neri
Oct 3, 2002·American Journal of Public Health·Vincent M B Silenzio
Oct 3, 2002·American Journal of Public Health·Gerard Bodeker, Fredi Kronenberg
Oct 3, 2002·American Journal of Public Health·Bentson McFarlandMark Kaplan
Oct 3, 2002·American Journal of Public Health·Chi-Keong OngSarah Stewart-Brown
May 15, 2003·Disability and Rehabilitation·Shawn C Bingham, Phillip W Beatty
May 30, 2003·American Journal of Public Health·Andrew S LondonMartin F Shapiro

❮ Previous
Next ❯

Citations

Oct 13, 2006·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Audrey CottencinPaul C Sorum
Dec 1, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Vicki McManus, Maggie Gliksten
Oct 18, 2012·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Catherine A OkoroLina S Balluz
Nov 26, 2013·BMC Complementary and Alternative Medicine·Barbara J StussmanRichard L Nahin
Feb 13, 2007·BMC Complementary and Alternative Medicine·Kathi J KemperMelissa Pennington
Apr 11, 2008·BMC Complementary and Alternative Medicine·Kathi J Kemper, Kaylene L Hood
Oct 4, 2011·Disability and Rehabilitation·Catherine A OkoroLina S Balluz
Oct 27, 2012·PM & R : the Journal of Injury, Function, and Rehabilitation·Maulik P PurohitRussell S Phillips
Aug 11, 2011·Complementary Therapies in Medicine·Catherine A OkoroLina S Balluz
Feb 15, 2011·Research in Developmental Disabilities·Roland M DardennesNesreen N Al Anbar
Aug 25, 2010·Journal of Manipulative and Physiological Therapeutics·Harrison NdetanKaran P Singh
Nov 26, 2008·Complementary Therapies in Medicine·Eran Ben-Arye, Moshe Frenkel
May 13, 2009·Journal of the American Academy of Nurse Practitioners·Kathryn A HeimerSherrie Rubio-Wallace
Oct 24, 2014·Neuropsychological Rehabilitation·Elena GoodrichBarry S Oken
Jun 23, 2007·Neuropharmacology·Abbas Mirshafiey
Oct 15, 2009·Multiple Sclerosis : Clinical and Laboratory Research·C M HughesA S Lowe-Strong
May 15, 2013·Journal of Child Neurology·Annette MajnemerUNKNOWN Group the QUALA

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.